Mesoporous Nanoparticle-Based Anticancer Therapies

The use of nanocarriers as drug delivery agents (DDA) has now gained considerable attention due to their targeted therapy and fewer side effects. Mesoporous silica nanoparticles (MSNs) have recently gained more attraction for various biological, pharmaceutical, and theranostics applications due to the unique ability of these particles to access the targeted sites. Their special structural qualities make them ideal for efficiently transporting therapeutic medications to preclude disease development, decrease inflammatory diseases, and ultimately increase cancer treatment. The popularity of MSNs is a result of their distinctive qualities, including their increased surface area and pore volume, customizable particle and pore size, ease of surface functionalization or activation and variation, high stability, and capacity to effectively capture drug molecules. This chapter illustrates the qualities and recent progression of MSNs as drug delivery particles for the treatment of cancer. In addition, MSNs are used as a multifunctional DDA that might be used for both cancer diagnosis and treatment.